Background: Plasma levels of low-density lipoprotein cholesterol (LDL-C) are a major risk factor for cardiovascular disease and are influenced by both heredity and dietary habits. The Niemann-Pick C1 like 1 (NPC1L1) protein mediates efficient dietary cholesterol absorption and contributes to variations in human LDL-C levels.
Methods: In the present study, using high throughput sequencing we identified three non-synonymous (NS) variations and 64 synonymous variations in the NPC1L1 gene from subsets of Chinese Han, Uygur and Kazakh populations with high or low LDL-C. Subsequently, three NS variations encoding R174H, V177I and V1284L substitutions were observed only in Uygur and Kazakh individuals with limited maximal plasma LDL-C levels.
Results: In further experiments, we investigated cholesterol-regulated recycling and glycosylation and stability of these NS NPC1L1 variants. However, no significant differences between WT and variant NPC1L1 proteins were observed using in vivo assays in mouse livers with adenovirus-mediated expression, demonstrating that none of the three NPC1L1 NS variants caused decreased uptake of biliary cholesterol.
Conclusions: Simultaneously, these data indicate that R174H, V177I and V1284L NPC1L1 variations in high or low LDL-C individuals may not directly influence cholesterol absorption by NPC1L1.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bbrc.2016.09.164 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Genetic correlation between genes targeted by lipid-lowering drugs and venous thromboembolism: A drug-target Mendelian randomization study.
Medicine (Baltimore)
December 2024
National Clinical Research Center for Chinese Medicine Cardiology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing, China.
Dyslipidemia has been established as a potential risk factor for venous thromboembolism (VTE) in several observational studies. Statins and novel lipid-modifying agents are being explored for their potential in VTE prevention, encompassing deep vein thrombosis (DVT), and pulmonary embolism (PE). Nonetheless, conclusive evidence supporting the effectiveness remains uncertain.
View Article and Find Full Text PDFLipid-lowering drugs, circulating inflammatory factors, and atrial fibrillation: a mediation Mendelian randomization study.
Front Cardiovasc Med
November 2024
Preventive Treatment Center, The First Hospital of Hunan University of Chinese Medicine, Changsha, China.
Background: Previous studies have shown an association between lipid-lowering drugs, circulating inflammatory factors, and atrial fibrillation (AF), but the specific effects of lipid-lowering drugs on AF and whether they can be mediated by circulating inflammatory factors remain unclear.
Methods: We collected 10 genetic variants encoding lipid-lowering drug targets (LDLR, HMGCR, PCSK9, NPC1L1, APOB, APOB, ABCG5, ABCG8, LPL, APOC3, and PPARA) and AF based on genome-wide association study (GWAS) summary statistics. Drug target Mendelian randomization (MR) was used to explore the causal relationship between lipid-lowering drugs and AF.
Evaluation of the role of metabolizing enzymes and transporter variants in ezetimibe pharmacokinetics.
Front Pharmacol
October 2024
Clinical Pharmacology Department, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria La Princesa (IIS-Princesa), Madrid, Spain.
Introduction: Ezetimibe inhibits cholesterol uptake by modulation of intestinal sterol absorption. Currently, although some studies have shown alterations in ezetimibe levels caused by alterations in the , , or genes, there are no pharmacogenetic guidelines to confirm these biomarkers. The aim of this work was to evaluate the effect of 49 variants in 22 pharmacogenes related to metabolism and transport.
View Article and Find Full Text PDFHMGCR as a promising molecular target for therapeutic intervention in aortic aneurisms: a mendelian randomization study.
Nutr Metab (Lond)
October 2024
Cardiology Department, Hunan Provincial People's Hospital, No.61 West Jiefang Road, Furong District, Changsha, Hunan, 410000, China.
Article Synopsis
- - The study investigates the causal relationship between low-density lipoprotein cholesterol (LDL-C) levels and different types of aneurisms, using statistical methods like Mendelian Randomization (MR) to analyze genetic data related to LDL-C-lowering targets.
- - Results indicate that increased expression of the HMGCR gene significantly elevates the risk of aortic, thoracic, and abdominal aneurisms, with strong odds ratios showing a clear association.
- - Additionally, after adjusting for factors like body mass index and smoking, similar positive associations were found for PCSK9 and CETP genes concerning the risk of various aortic aneurisms.
Association of lipids and lipid-lowering drugs with peripheral arterial disease: A Mendelian randomization study.
J Clin Lipidol
July 2024
Security Department, The First Affiliated Hospital of Wannan Medical College, Wuhu, 241001, China (Mr Ping). Electronic address:
Background: It remains unclear whether lipid profiles and lipid-lowering medications are causally related to PAD.
Objective: Explain whether there is a causal relationship between lipid status and lipid-lowering drugs and PAD.
Methods: In this two-sample Mendelian randomization (MR) analysis, we assessed the causal relationship between lipid traits, including high-density lipoprotein (HDL), low-density lipoprotein (LDL), triglycerides (TGs), total cholesterol (TC), and LDL-associated genetic variants (HMGCR, NPC1L1, PCSK9, APOB), and the risk of peripheral arterial disease (PAD) using genetic variants associated with these lipid markers.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!